A Win For Calidi Biotherapeutics Inc.
Thu, Feb 22, 2024 at 07:14 PM
Calidi Biotherapeutics Inc. (CLDI:NYSEMKT) jumped higher at $0.99, a gain of 52.5%. On Thu, Feb 22, 2024, CLDI:NYSEMKT touched a New 2-Week High of $0.99. The stock appeared on our News Catalysts scanner on Mon, Feb 12, 2024 at 08:24 AM in the 'MISCELLANEOUS' category. From Fri, Feb 09, 2024, the stock recorded 62.50% Up Days and 44.44% Green Days
The stock spiked on Thu, Feb 22, 2024 at $1.44 with a volume of 6M+.
About Calidi Biotherapeutics Inc. (CLDI:NYSEMKT)
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the price and yield performance of the FLAGLSX-Forensic Accounting Long-Short Index.
Top 10 Gainers:
- Monopar Therapeutics Inc. (MNPR:NASDAQ), 96.49%
- La Rosa Holdings Corp. (LRHC:NASDAQ), 95.71%
- Dogness (International) Corporation (DOGZ:NASDAQ), 64.08%
- BuzzFeed Inc. (BZFD:NASDAQ), 58.1%
- Root Inc. (ROOT:NASDAQ), 53.29%
- Calidi Biotherapeutics Inc. (CLDI:NYSEMKT), 52.49%
- Quantum FinTech Acquisition Corporation (QFTA:NYSEMKT), 51.33%
- Quantum FinTech Acquisition Corporation (QFTA:NYSE), 51.33%
- Infobird Co. Ltd (IFBD:NASDAQ), 48%
- Venus Concept Inc. (VERO:NASDAQ), 45.31%